Sleep disorders constitute a major public health concern due to their high frequency and their impact on alertness and overall health. The objective of this study was to assess sleep disorders and factors associated among diabetic patients attending public healthcare facilities in the Mopti Region in 2022. Methodology: A cross sectional study was conducted from March 1 to August 31, 2022. The study population was diabetic patients attending healthcare facilities in the Mopti region. Patients aged 18 years and older, attending public healthcare facilities and who provided informed consent, were included. A total of 289 patients were included in the study. Data were collected using a standardized questionnaire, including the Berlin Questionnaire, and were analyzed using SPSS software version 25. Results: The mean age of participants was 51.59 ± 11.39 years. Type 2 diabetes accounted for 66.9% of cases. The mean body mass index (BMI) was 27.62 ± 4.26 kg/m², and the mean sleep duration was 5.76 ± 1.43 hours per day. A high risk of obstructive sleep apnea syndrome (OSAS) was observed in 92.4% of participants. Variables statistically associated with the dependent variable (OSAS) included high blood pressure (OR = 52.4; 95% CI: 1.63–16.8), Tobacco no use (OR = 0.04; 95% CI: 0.03–0.70) and BMI ≥ 25 (OR = 3; 95% CI: 1.20–7.50) Conclusion: This study reveals a high frequency of sleep disorders among diabetic patients in the Mopti region. A nationwide study is warranted to better estimate the prevalence of this condition and to inform the implementation of effective control strategies. These findings highlight the need for large-scale national studies to more accurately estimate the burden of this condition and to guide the implementation of effective prevention and control strategies.
| Published in | Science Journal of Public Health (Volume 14, Issue 2) |
| DOI | 10.11648/j.sjph.20261402.16 |
| Page(s) | 105-113 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2026. Published by Science Publishing Group |
Sleep Disorders, Obstructive Sleep Apnea, Diabetes Mellitus, Obesity, Mali
Variables | n | % | Means ± SD* |
|---|---|---|---|
Age (year) n= 196 | 51.59 ± 11.39 | ||
Sex (n=196) | |||
Male | 57 | 29.1 | |
Female | 139 | 70.9 | |
Marital Status (n=195) | |||
Single | 9 | 4.6 | |
Married | 140 | 71.8 | |
Divorced | 4 | 2.1 | |
Widowed | 42 | 21.5 | |
Level of Education (n=189) | |||
None | 116 | 61.4 | |
Primary | 47 | 24.9 | |
Secondary | 18 | 9.5 | |
Tertiary | 8 | 4.2 | |
Residence (n=193) | |||
Rural | 22 | 11.4 | |
Urban | 171 | 88.6 | |
Type of diabetes (n= 151) | |||
Type 1 | 50 | 33.1 | |
Type 2 | 101 | 66.9 |
Variables | n | % | Means ± SD |
|---|---|---|---|
Physical activity (n=165) | |||
Yes | 124 | 75.2 | |
No | 41 | 24.8 | |
Frequency per week (n=128) | |||
< 5 | 77 | 61.1 | |
≥ 5 | 49 | 38.9 | |
Duration per session (minutes) (n=118) | 72.33 ± 35.45 | ||
Tobacco use (n=143) | |||
Current smoker | 8 | 5.6 | |
Non-smoker | 110 | 76.9 | |
Former smoker | 25 | 17.5 | |
Alcohol consumption (n=125) | |||
Consumer | 1 | 0.8 | |
Non-consumer | 120 | 96.0 | |
Former consumer | 4 | 3.2 | |
Other psychoactive substances | |||
Cannabis (hashish) (n=136) | 0 | 0.0 | |
Kif (n=136) | 1 | 0.7 | |
Nefha (smokeless tobacco) (n=138) | 15 | 10.9 | |
Shisha (water pipe) (n=136) | 3 | 2.2 |
Variables | N | % | Means ± SD |
|---|---|---|---|
Sleep habits | |||
Sleep duration per day (hour) n= 191 | 5.76 ± 1.43 | ||
≥ 8 hours | 28 | 14.7 | |
˂ 8 hours | 163 | 85.3 | |
Time to fall asleep (minutes) n=178 | 57.16 ± 36.14 | ||
Regular sleep pattern (n= 195) | |||
Yes | 66 | 33.8 | |
No | 129 | 66.2 | |
Daytime napping (siesta) (n=195) | |||
Yes | 148 | 75.9 | |
No | 47 | 24.1 | |
Physical activity before sleep (n=189) | |||
Yes | 159 | 84.1 | |
No | 30 | 15.9 | |
Stress level (n=192) | |||
Low level | 17 | 8.9 | |
Medium level | 99 | 51.6 | |
High level | 69 | 35.9 | |
Very high | 7 | 3.6 | |
Depressive symptoms | |||
Mood disturbances (n=196) | |||
Yes | 174 | 88.8 | |
No | 22 | 11.2 | |
Memory impairment (n=192) | |||
Yes | 101 | 52.6 | |
No | 91 | 47.4 | |
Irritability (n=196) | |||
Yes | 166 | 84.7 | |
No | 30 | 15.3 | |
Difficulty concentrating (n=193) | |||
Yes | 91 | 47.2 | |
No | 102 | 52.8 | |
Sexual health | |||
Libido problems (n=168) | |||
Yes | 17 | 10.1 | |
No | 151 | 89.9 |
Variables | Low risk n (%) | High risk n (%) | p-value (Univariate) | Adjusted OR (aOR) | 95% CI | p-value |
|---|---|---|---|---|---|---|
Age (years), Mean ± SD | 42.07 ± 13.73 | 52.39 ± 10.88 | <0.001 | 1.1 | 0.9–1.1 | 0.09 |
Diabetes duration (years), Mean ± SD | 5.65 ± 5.47 | 9.06 ± 5.73 | 0.02 | 1.1 | 0.9–1.3 | 0.08 |
Sex | ||||||
Male | 9 (6.5) | 51 (89.5) | Ref | 1 | - | - |
Female | 6 (10.5) | 129 (93.5) | 0.37 | 0.3 | 0.06–1.4 | 0.12 |
Type of diabetes | ||||||
Type 1 | 8 (7.9) | 93 (92.1) | Ref | - | - | - |
Type 2 | 3 (6.0) | 47 (94.0) | 1.00 | - | - | - |
Hypertension | ||||||
No | 14 (26.4) | 39 (73.6) | Ref | 1 | - | - |
Yes | 1 (0.7) | 141 (99.3) | <0.001 | 5.24 | 1.63–16.8 | <0.001 |
Dyslipidemia | ||||||
No | 13 (10.9) | 106 (89.1) | Ref | 1 | - | - |
Yes | 2 (2.6) | 75 (97.4) | 0.05 | 1.1 | 0.1–9.2 | 0.90 |
Cardiovascular disease | ||||||
No | 14 (8.0) | 161 (92.0) | Ref | 1 | - | - |
Yes | 1 (4.8) | 20 (95.2) | 1.00 | 7.3 | 0.3–15.0 | 0.19 |
Intense physical activity (occupation) | ||||||
Yes | 8 (16.0) | 42 (84.0) | Ref | 1 | - | - |
No | 6 (4.4) | 130 (95.6) | <0.01 | 14.8 | 0.1–15.3 | 0.08 |
Tobacco use | ||||||
Yes | 3 (37.5) | 5 (62.5) | Ref | 1 | - | - |
No | 11 (8.1) | 124 (91.9) | 0.03 | 0.04 | 0.03–0.70 | 0.02 |
Harmful substance use | ||||||
No | 10 (7.6) | 122 (92.4) | - | - | - | - |
Yes | 3 (5.3) | 54 (94.7) | 0.75 | - | - | - |
Sleep duration ≤ 8 h/day | ||||||
No | 12 (7.4) | 151 (92.6) | - | - | - | - |
Yes | 2 (7.1) | 26 (92.9) | 1.00 | - | - | - |
Sleep regularity | ||||||
Yes | 6 (9.1) | 60 (90.9) | - | - | - | - |
No | 9 (7.0) | 120 (93.0) | 0.58 | - | - | - |
Mood disturbances | ||||||
No | 5 (22.7) | 17 (77.3) | Ref | 1 | - | - |
Yes | 9 (5.2) | 165 (94.8) | <0.01 | 0.2 | 0.02–2.9 | 0.29 |
Irritability | ||||||
No | 7 (23.3) | 23 (76.7) | Ref | 1 | - | - |
Yes | 7 (4.2) | 159 (95.8) | 0.002 | 0.7 | 0.08–6.7 | 0.81 |
Difficulty concentrating | ||||||
No | 11 (10.8) | 91 (89.2) | Ref | 1 | - | - |
Yes | 2 (2.2) | 89 (97.8) | 0.02 | 1.0 | 0.15–5.2 | 0.28 |
Body Mass Index (kg/m²) | ||||||
< 25 | 12 (9.3) | 117 (90.7) | Ref | 1 | - | - |
≥ 25 | 3 (4.8) | 59 (95.2) | 0.39 | 3.0 | 1.20–7.50 | 0.04 |
OSAS | Sleep Apnea Syndrome |
BMI | Body Mass Index |
| [1] | Sateia, M. J. International Classification of Sleep Disorders-Third Edition. Chest 146, 1387–1394 (2014). |
| [2] | Roth, T. Insomnia: definition, prevalence, etiology, and consequences. J. Clin. Sleep Med. JCSM Off. Publ. Am. Acad. Sleep Med. 3, S7-10 (2007). |
| [3] | Komolafe, M. A. et al. Sleep medicine in Africa: past, present, and future. J. Clin. Sleep Med. JCSM Off. Publ. Am. Acad. Sleep Med. 17, 1317–1321 (2021). |
| [4] | Fallahi, A., Jamil, D. I., Karimi, E. B., Baghi, V. & Gheshlagh, R. G. Prevalence of obstructive sleep apnea in patients with type 2 diabetes: A systematic review and meta-analysis. Diabetes Metab. Syndr. Clin. Res. Rev. 13, 2463–2468 (2019). |
| [5] | Tassew, W. C., Woldie, S. S., Ferede, Y. A. & Zeleke, A. M. Obstructive sleep apnea risk and associated factors among patients with type 2 diabetes mellitus in Africa: systematic review and meta-analysis. Sleep Sci. Pract. 8, 14 (2024). |
| [6] | Diall, H. Sleep Disorders and Road Traffic Accidents among Truck Drivers in Bamako. |
| [7] | Hirshkowitz, M. et al. National Sleep Foundation’s sleep time duration recommendations: methodology and results summary. Sleep Health 1, 40–43 (2015). |
| [8] | Cappuccio, F. P., D’Elia, L., Strazzullo, P. & Miller, M. A. Sleep Duration and All-Cause Mortality: A Systematic Review and Meta-Analysis of Prospective Studies. |
| [9] | Netzer NC, Stoohs RA, Netzer CM, Clark K, Strohl KP. Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Ann Intern Med. 1999; 131(7): 485-491. |
| [10] | Ahn E, Baek Y, Park J- E, et al. Elevated prevalence and treatment of sleep disorders from 2011 to 2020: a nationwide population- based retrospective cohort study in Korea. BMJ Open 2024;14:e075809. |
| [11] | Saxena, P., Singh, D. & Singh, Y. Prevalence and impact of obstructive sleep apnea in type 2 diabetes mellitus: A descriptive cross-sectional study. Med. J. Armed Forces India 80, S50–S56 (2024). |
| [12] | Ade, S. et al. Risk of obstructive sleep apnea and quality of sleep among adults with type 2 diabetes mellitus in a sub-Saharan Africa city. Pan Afr. Med. J. 40, 264 (2021). |
| [13] | Neikrug, A. B. & Ancoli-Israel, S. Sleep disorders in the older adult - a mini-review. Gerontology 56, 181–189 (2010). |
| [14] | Ohayon, M. M. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med. Rev. 6, 97–111 (2002). |
| [15] | Zhang, B. & Wing, Y.-K. Sex differences in insomnia: a meta-analysis. Sleep 29, 85–93 (2006). |
| [16] | Krishnan, V. & Collop, N. A. Gender differences in sleep disorders. Curr. Opin. Pulm. Med. 12, 383–389 (2006). |
| [17] | Chaput, J.-P. et al. Sleep duration and health in adults: an overview of systematic reviews. Appl. Physiol. Nutr. Metab. 45, S218–S231 (2020). |
| [18] | Chaput, J.-P. et al. Sleep Irregularity and the Incidence of Type 2 Diabetes: A Device-Based Prospective Study in Adults. Diabetes Care 47, 2139–2145 (2024). |
| [19] | Nôga, D. A. et al. Habitual Short Sleep Duration, Diet, and Development of Type 2 Diabetes in Adults. JAMA Netw. Open 7, e241147 (2024). |
| [20] | Diarra, A. S. et al. Factors associated with obstructive sleep apnea syndrome in diabetics attending state health structures in the Mopti region in Mali. MOJ Public Health 14, (2025). |
| [21] | Jaehne, A., Loessl, B., Bárkai, Z., Riemann, D. & Hornyak, M. Effects of nicotine on sleep during consumption, withdrawal and replacement therapy. Sleep Med. Rev. 13, 363–377 (2009). |
| [22] | He, S., Hasler, B. P. & Chakravorty, S. Alcohol and Sleep-Related Problems. Curr. Opin. Psychol. 30, 117–122 (2019). |
| [23] | Ohkuma, T. et al. Association between sleep duration and urinary albumin excretion in patients with type 2 diabetes: the Fukuoka diabetes registry. PloS One 8, e78968 (2013). |
| [24] | Gangwisch, J. E. et al. Sleep duration as a risk factor for diabetes incidence in a large U.S. sample. Sleep 30, 1667–1673 (2007). |
| [25] | Lo, C.-F. Critically Discuss the Effects of Sleep on Long-Term Memory. Psychology 9, 561–569 (2018). |
| [26] | Tasali, E., Mokhlesi, B. & Van Cauter, E. Obstructive sleep apnea and type 2 diabetes: interacting epidemics. Chest 133, 496–506 (2008). |
| [27] | The Occurrence Of Sleep-Disordered Breathing... : New England Journal of Medicine. Ovid |
| [28] | Daniel, M. M., Lorenzi, M. C., Leite, C. da C. & Lorenzi-Filho, G. PHARYNGEAL DIMENSIONS IN HEALTHY MEN AND WOMEN. Clinics 62, 5–10 (2007). |
| [29] | Jordan, A. S., McSharry, D. G. & Malhotra, A. Adult obstructive sleep apnoea. Lancet 383, 736–747 (2014). |
| [30] | Schwartz, A. R. et al. Obesity and Obstructive Sleep Apnea: Pathogenic Mechanisms and Therapeutic Approaches. Proc. Am. Thorac. Soc. 5, 185–192 (2008). |
| [31] | Young T, Peppard P, and Gottlieb D: Epidemiology of Obstructive Sleep Apnea: A Population Health Perspective. Am J Respir Crit Care Med 2002; 165: 1217–1239. |
| [32] | Durán J, Esnaola S, Rubio R, Iztueta A. Obstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med. 2001 Mar; 163(3 Pt 1): 685–9. |
| [33] | Zaibi H, Ben Mansour A, Ben Ammar J, Neffati O, Baccar M, Azzebi S, et al. Smoking and Obstructive Sleep Apnea Syndrome: Impact on Prevalence and Severity. Rev Mal Respir. 2016 Jan 1; 33: A265. |
| [34] | Peppard P, Austin D, Brown R. Association of alcohol consumption and sleep disordered breathing in men and women. J Clin Sleep Med JCSM Off Publ Am Acad Sleep Med. 2007 Apr 15; 3(3): 265–70. |
| [35] | Peppard PE, Young T, Palta M, Dempsey J, Skatrud J. Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA. 2000 Dec 20; 284(23): 3015–21. |
| [36] | Keskin A, Ünalacak M, Bilge U, Yildiz P, Güler S, Selçuk EB, et al. Effects of Sleep Disorders on Hemoglobin A1c Levels in Type 2 Diabetic Patients. Chin Med J (Engl). 2015; 128(24): 3292. |
APA Style
Diarra, A. S., Diarra, M., Toure, D., Sangho, O., Keita, S., et al. (2026). Assessment of Sleep Duration, Behavioral Habits and Factors Associated with Sleep Disorders Among Diabetic Patients in the Mopti Region, Mali, 2022. Science Journal of Public Health, 14(2), 105-113. https://doi.org/10.11648/j.sjph.20261402.16
ACS Style
Diarra, A. S.; Diarra, M.; Toure, D.; Sangho, O.; Keita, S., et al. Assessment of Sleep Duration, Behavioral Habits and Factors Associated with Sleep Disorders Among Diabetic Patients in the Mopti Region, Mali, 2022. Sci. J. Public Health 2026, 14(2), 105-113. doi: 10.11648/j.sjph.20261402.16
AMA Style
Diarra AS, Diarra M, Toure D, Sangho O, Keita S, et al. Assessment of Sleep Duration, Behavioral Habits and Factors Associated with Sleep Disorders Among Diabetic Patients in the Mopti Region, Mali, 2022. Sci J Public Health. 2026;14(2):105-113. doi: 10.11648/j.sjph.20261402.16
@article{10.11648/j.sjph.20261402.16,
author = {Abdoul Salam Diarra and Mohamed Diarra and Dramane Toure and Oumar Sangho and Salia Keita and Bakary Diarra and Housseini Dolo and Cheick Abou Coulibaly and Nouhoum Telly and Fanta Sangho and Lancina Doumbia and Borodjan Diarra and Oumar Traore and Hamadoun Sangho},
title = {Assessment of Sleep Duration, Behavioral Habits and Factors Associated with Sleep Disorders Among Diabetic Patients in the Mopti Region, Mali, 2022},
journal = {Science Journal of Public Health},
volume = {14},
number = {2},
pages = {105-113},
doi = {10.11648/j.sjph.20261402.16},
url = {https://doi.org/10.11648/j.sjph.20261402.16},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.sjph.20261402.16},
abstract = {Sleep disorders constitute a major public health concern due to their high frequency and their impact on alertness and overall health. The objective of this study was to assess sleep disorders and factors associated among diabetic patients attending public healthcare facilities in the Mopti Region in 2022. Methodology: A cross sectional study was conducted from March 1 to August 31, 2022. The study population was diabetic patients attending healthcare facilities in the Mopti region. Patients aged 18 years and older, attending public healthcare facilities and who provided informed consent, were included. A total of 289 patients were included in the study. Data were collected using a standardized questionnaire, including the Berlin Questionnaire, and were analyzed using SPSS software version 25. Results: The mean age of participants was 51.59 ± 11.39 years. Type 2 diabetes accounted for 66.9% of cases. The mean body mass index (BMI) was 27.62 ± 4.26 kg/m², and the mean sleep duration was 5.76 ± 1.43 hours per day. A high risk of obstructive sleep apnea syndrome (OSAS) was observed in 92.4% of participants. Variables statistically associated with the dependent variable (OSAS) included high blood pressure (OR = 52.4; 95% CI: 1.63–16.8), Tobacco no use (OR = 0.04; 95% CI: 0.03–0.70) and BMI ≥ 25 (OR = 3; 95% CI: 1.20–7.50) Conclusion: This study reveals a high frequency of sleep disorders among diabetic patients in the Mopti region. A nationwide study is warranted to better estimate the prevalence of this condition and to inform the implementation of effective control strategies. These findings highlight the need for large-scale national studies to more accurately estimate the burden of this condition and to guide the implementation of effective prevention and control strategies.},
year = {2026}
}
TY - JOUR T1 - Assessment of Sleep Duration, Behavioral Habits and Factors Associated with Sleep Disorders Among Diabetic Patients in the Mopti Region, Mali, 2022 AU - Abdoul Salam Diarra AU - Mohamed Diarra AU - Dramane Toure AU - Oumar Sangho AU - Salia Keita AU - Bakary Diarra AU - Housseini Dolo AU - Cheick Abou Coulibaly AU - Nouhoum Telly AU - Fanta Sangho AU - Lancina Doumbia AU - Borodjan Diarra AU - Oumar Traore AU - Hamadoun Sangho Y1 - 2026/04/23 PY - 2026 N1 - https://doi.org/10.11648/j.sjph.20261402.16 DO - 10.11648/j.sjph.20261402.16 T2 - Science Journal of Public Health JF - Science Journal of Public Health JO - Science Journal of Public Health SP - 105 EP - 113 PB - Science Publishing Group SN - 2328-7950 UR - https://doi.org/10.11648/j.sjph.20261402.16 AB - Sleep disorders constitute a major public health concern due to their high frequency and their impact on alertness and overall health. The objective of this study was to assess sleep disorders and factors associated among diabetic patients attending public healthcare facilities in the Mopti Region in 2022. Methodology: A cross sectional study was conducted from March 1 to August 31, 2022. The study population was diabetic patients attending healthcare facilities in the Mopti region. Patients aged 18 years and older, attending public healthcare facilities and who provided informed consent, were included. A total of 289 patients were included in the study. Data were collected using a standardized questionnaire, including the Berlin Questionnaire, and were analyzed using SPSS software version 25. Results: The mean age of participants was 51.59 ± 11.39 years. Type 2 diabetes accounted for 66.9% of cases. The mean body mass index (BMI) was 27.62 ± 4.26 kg/m², and the mean sleep duration was 5.76 ± 1.43 hours per day. A high risk of obstructive sleep apnea syndrome (OSAS) was observed in 92.4% of participants. Variables statistically associated with the dependent variable (OSAS) included high blood pressure (OR = 52.4; 95% CI: 1.63–16.8), Tobacco no use (OR = 0.04; 95% CI: 0.03–0.70) and BMI ≥ 25 (OR = 3; 95% CI: 1.20–7.50) Conclusion: This study reveals a high frequency of sleep disorders among diabetic patients in the Mopti region. A nationwide study is warranted to better estimate the prevalence of this condition and to inform the implementation of effective control strategies. These findings highlight the need for large-scale national studies to more accurately estimate the burden of this condition and to guide the implementation of effective prevention and control strategies. VL - 14 IS - 2 ER -